Literature DB >> 3946413

Progressive vascular calcification with necrosis of extremities in hemodialysis patients: a possible role of iron overload.

D Rubinger, M M Friedlaender, J Silver, Y Kopolovic, W J Czaczkes, M M Popovtzer.   

Abstract

Progressive vascular calcification with ischemia and gangrene of the extremities occurs rarely in uremic patients, patients undergoing maintenance dialysis, and following renal transplantation. In this paper we present two additional patients on chronic hemodialysis who developed this syndrome in association with severe secondary hyperparathyroidism. Fulminant gangrene led to the death of the first patient, while in the second, multiple amputations had to be performed after parathyroidectomy. In both patients, evidence of iron overload due to multiple blood transfusions was present and iron was histologically demonstrated in a calcification area in one case. The possibility of iron overload as a "challenger" for systemic calciphylaxis is discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3946413     DOI: 10.1016/s0272-6386(86)80132-9

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  8 in total

1.  Health economic evaluation of paricalcitol(®) versus cinacalcet + calcitriol (oral) in Italy. [corrected].

Authors:  Mark Nuijten; Daniela P Roggeri; Alessandro Roggeri; Paolo Novelli; Thomas S Marshall
Journal:  Clin Drug Investig       Date:  2015-04       Impact factor: 2.859

2.  Fatal calciphylaxis in two patients with giant cell arteritis.

Authors:  K Brouns; E Verbeken; H Degreef; H Bobbaers; D Blockmans
Journal:  Clin Rheumatol       Date:  2006-07-27       Impact factor: 2.980

3.  Calciphylaxis in pediatric end-stage renal disease.

Authors:  Abubakr A Imam; Tej K Mattoo; Gaurav Kapur; David A Bloom; Rudolph P Valentini
Journal:  Pediatr Nephrol       Date:  2005-08-25       Impact factor: 3.714

4.  Cost Effectiveness of Paricalcitol versus a non-selective vitamin D receptor activator for secondary hyperparathyroidism in the UK: a chronic kidney disease markov model.

Authors:  Mark Nuijten; Dennis L Andress; Steven E Marx; Alistair S Curry; Raimund Sterz
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

5.  The Effect of Paricalcitol on Vascular Calcification and Cardiovascular Disease in Uremia: Beyond PTH Control.

Authors:  Mario Cozzolino; Florjan Mehmeti; Paola Ciceri; Elisa Volpi; Andrea Stucchi; Irene Brenna; Daniele Cusi
Journal:  Int J Nephrol       Date:  2011-03-29

6.  Treatment of severe metastatic calcification and calciphylaxis in dialysis patients.

Authors:  Saurabh K Goel; Keith Bellovich; Peter A McCullough
Journal:  Int J Nephrol       Date:  2011-02-24

7.  Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysis.

Authors:  Suwasin Udomkarnjananun; Kitravee Kongnatthasate; Kearkiat Praditpornsilpa; Somchai Eiam-Ong; Bertrand L Jaber; Paweena Susantitaphong
Journal:  Kidney Int Rep       Date:  2018-10-09

Review 8.  The Role of Iron in Calciphylaxis-A Current Review.

Authors:  Olivia Wickens; Sharmilee Rengarajan; Rajkumar Chinnadurai; Ian Ford; Iain C Macdougall; Philip A Kalra; Smeeta Sinha
Journal:  J Clin Med       Date:  2022-09-29       Impact factor: 4.964

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.